Welcome to the new Gustave Roussy website

A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.

News

French and American experts share their knowledge on latest advances and perspectives in Immuno-Oncology

Published on May 03 2022

Save the date : Friday the 13th of May 2:30 pm (CEST) for the first online conference dedicated to immuno-oncology set up between the Dana Farber Cancer Institute and Gustave Roussy/Paris-Saclay University. Medscape platform will broadcast this unique virtual event supported by the Institut Servier. Program and free registration on : https://na.eventscloud.com/website/38351/

The Dana Farber Cancer Institute, American center ranked #3 world’s best oncology hospital according to Newsweek Magazine, and Gustave Roussy, leading cancer center in Europe, share the same ambitions: Improve knowledge in both research and care to offer the best treatment to their patients and anticipate the awareness evolution about cancer.

Experts sharing a Master class

To attend this first online high level conference dedicated to the latest savoir in immuno-oncology’s clinical research join the platform at 8:30 am EST / 2:30 pm CEST Friday the 13th of May 2022. This Premiere will be live from Boston, Massachussetts (United-States). The two Chairmen of the conference, Pr Toni Choueri, MD, Director of the Lank Center for Genitourinary (GU) Oncology at Dana Farber Cancer Institute, and Pr Fabrice Barlesi, Gustave Roussy’s CEO, will open the meeting. Professor William G. Kaelin, 2019 Nobel in Physiology and Medicine will give the keynote address. It will be followed by 12 sessions in which several internationally renowned experts will present and share the results of their work.

A very broad spectrum of recent advances in immuno-oncology will be covered :
VHL Tumor Suppressor Gene, Microbiota-Centered Interventions, CAR T Cell Therapy....
The conference will be moderated by Pr Fabrice André, Gustave Roussy’s Director of Research, Pr Guido Kroemer, Gustave Roussy, and Pr Kai Wucherpfenning, Dana Farber Cancer Institute. Each 30 minutes’s presentation will be followed by some Q&A time for.

“The Transatlantic-Exchanges in Immuno-Oncology” will also mark the launch of the annual ”Dana-Farber / Gustave Roussy Days in Oncology“ meetings, a new conference cycle initiated by both the Dana Farber Cancer Institute, Gustave Roussy and l’Institut Servier.

Registration is free and open to everyone.

Online registration and program: https://na.eventscloud.com/website/38351/

Last news

Breast Cancer: Gustave Roussy Ranked No. 1 in France for Breast Surgery and Breast Reconstruction

On the occasion of Breast Cancer Awareness Month, the 2025 data from Visuchir, the national surgical activity monitoring tool of the French Health Insurance system, places Gustave Roussy in first position for both breast surgery and breast reconstruction. Beyond this ranking, these figures highlight that reconstruction is now an integral part of breast cancer treatment. It is considered at every stage of care: from tumor removal surgery, whether lumpectomy or mastectomy, through to the post-cancer period, helping to restore the body and support women in regaining their physical integrity and quality of life.
Newsweek Ranking: Gustave Roussy Named Europe’s Leading Cancer Centre and Third Best Worldwide

The 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best worldwide. This distinction highlights the excellence of the Institute’s care and research, as well as the daily commitment of all its professionals.
Living with and beyond cancer: the promises and challenges of digital health

In a Viewpoint article published in The Lancet Digital Health, Drs Ines Vaz-Luis and Maria Alice Franzoi, together with Emmanuel Mussault, a patient partner at the PRISM University Hospital Institute, examine the role that digital tools can play in supporting people living with and beyond cancer. Their central message is that these technologies can support more personalised and accessible care, but their value depends primarily on how they are integrated into care pathways, the human support provided, their ability to address individual needs and their evaluation in real-world settings.
Gustave Roussy and The Lancet launch an international lecture series on innovations transforming cancer care

The inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading cancer prevention specialist at Harvard University and the Dana-Farber Cancer Institute.

Breast Cancer: Gustave Roussy Ranked No. 1 in France for Breast Surgery and Breast Reconstruction

On the occasion of Breast Cancer Awareness Month, the 2025 data from Visuchir, the national surgical activity monitoring tool of the French Health Insurance system, places Gustave Roussy in first position for both breast surgery and breast reconstruction. Beyond this ranking, these figures highlight that reconstruction is now an integral part of breast cancer treatment. It is considered at every stage of care: from tumor removal surgery, whether lumpectomy or mastectomy, through to the post-cancer period, helping to restore the body and support women in regaining their physical integrity and quality of life.
Newsweek Ranking: Gustave Roussy Named Europe’s Leading Cancer Centre and Third Best Worldwide

The 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best worldwide. This distinction highlights the excellence of the Institute’s care and research, as well as the daily commitment of all its professionals.
Living with and beyond cancer: the promises and challenges of digital health

In a Viewpoint article published in The Lancet Digital Health, Drs Ines Vaz-Luis and Maria Alice Franzoi, together with Emmanuel Mussault, a patient partner at the PRISM University Hospital Institute, examine the role that digital tools can play in supporting people living with and beyond cancer. Their central message is that these technologies can support more personalised and accessible care, but their value depends primarily on how they are integrated into care pathways, the human support provided, their ability to address individual needs and their evaluation in real-world settings.
Gustave Roussy and The Lancet launch an international lecture series on innovations transforming cancer care

The inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading cancer prevention specialist at Harvard University and the Dana-Farber Cancer Institute.

See all news